Delivering mitochondrial health
Abliva kommer att delta i CNS Summit 2024, som äger rum den 10-13 november på Encore Boston Harbor, Boston (USA). Företagets VD Ellen Donnelly har organiserat, och kommer den 11 november kl 13:00 ET att delta i, paneldiskussionen "Medicines for Mito: Developing Medicines for Mitochondrial Dysfunction Spotlight Session", med representanter från Stealth-, Tisento- och Saol […]
I slutet av juni kommer Abliva att medverka vid den amerikanska patientorganisationen UMDS:s Mitochondrial Disease Conference i Cleveland, Ohio. "Each year, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial medicine and the patients we serve. With over 700 attendees representing almost every state in the U.S. and more than 15 different countries, […]
Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial disease. There are currently no approved medicines for the systemic disease. The event will focus on Abliva's lead program, KL1333, which has shown clinically meaningful, […]
